# A Study for the Transdermal Application of Teriparatide

> **NCT01011556** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 233 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Subcutaneous Teriparatide
- **DRUG:** Transdermal Teriparatide

## Key facts

- **NCT ID:** NCT01011556
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 233 (ACTUAL)
- **Last updated:** 2012-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01011556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01011556, "A Study for the Transdermal Application of Teriparatide". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01011556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*